HAR §11-45-148. Vial shield labels

A licensee shall conspicuously label each vial radiation shield that contains a vial of a radiopharmaceutical with the radiopharmaceutical name or its abbreviation. [Eff 11/12/99] (Auth: HRS §§321-10, 321-11, 321-71) (Imp: HRS §§321-1, 321-11(21), 321-71) §11-45-149 Surveys for contamination and ambient radiation dose rate. (a) A licensee shall survey with a radiation detection survey instrument at the end of each day of use all areas where radiopharmaceuticals are routinely prepared for use or administered. (b) A licensee shall survey with a radiation detection survey instrument at least once each week all areas where radiopharmaceuticals or radioactive wastes are stored. (c) A licensee shall conduct the surveys required by subsections (a) and (b) so as to be able to measure dose rates as low as 0.1 millirem (one microsievert) per hour. (d) A licensee shall establish dose rate action levels for the surveys required by subsections (a) and (b) and shall require that the individual performing the survey immediately notify the radiation safety officer if a dose rate exceeds an action level. (e) A licensee shall survey for removable contamination each day of use all areas where radiopharmaceuticals are routinely prepared for use or administered and each week where radioactive materials are stored. (f) A licensee shall conduct the surveys required by subsection (e) so as to be able to detect contamination on each wipe sample of two thousand disintegrations per minute (33.3 becquerels). (g) A licensee shall establish removable contamination action levels for the surveys required by subsection (e) and shall require that the individual performing the survey immediately notify the radiation safety officer if contamination exceeds action levels. (h) A licensee shall retain a record of each survey required by subsections (a), (b), and (e). The record shall include the date of the survey, a sketch of each area surveyed, action levels established for each area, the measured dose rate at several points in each area expressed in millirems (microsieverts) per hour or the removable contamination in each area expressed in disintegrations per minute (becquerels) per one hundred square centimeters, the serial number and the model number of the instrument used to make the survey or analyze the samples, and the initials of the individual who performed the survey. [Eff 11/12/99] (Auth: HRS §§321-10, 321-11, 321-71) (Imp: HRS §§321-1, 321-11(21), 321-71) §11-45-150 Release of patients containing radiopharmaceuticals or permanent implants. A licensee shall not authorize release from confinement for medical care any patient administered a radiopharmaceutical or administered a permanent implant until the dose rate from the patient at the time of §11-45-150 45-130 release shall not result in a total effective dose equivalent exceeding five hundred millirems (five millisieverts) to any other individual during complete decay of the radionuclide. [Eff 11/12/99] (Auth: HRS §§321-10, 321-11, 321-71) (Imp: HRS §§321-1, 321-11(21), 321-71) §11-45-151 Mobile nuclear medicine service technical requirements. A licensee providing mobile nuclear medicine service shall: (1) Transport to each address of use only syringes or vials containing prepared radiopharmaceuticals or radiopharmaceuticals that are intended for reconstitution of radiopharmaceutical kits; (2) Bring into each area of use all radioactive material to be used and, before leaving, remove all unused radioactive material and associated radioactive waste; (3) Secure or keep under constant surveillance and immediate control all radioactive material when in transit or at an area of use; (4) In addition to complying with sections 11-45-140 and 11-45-141, check survey instruments and dose calibrators for constancy and response, and check all other transported equipment for proper function before medical use at each area of use; (5) Carry a survey meter calibrated in accordance with section 11-45-141 in each vehicle that is being used to transport radioactive material, and, before leaving a client area of use, survey all areas of radiopharmaceutical use with a radiation detection survey instrument to ensure that all radiopharmaceuticals and all associated radioactive waste have been removed; (6) Retain a record of each survey. The record shall include the date of the survey, a plan of each area that was surveyed, the measured dose rate at several points in each area of use expressed in millirem (millisieverts) per hour, the model and serial number of the instrument used to make the survey, and the initials of the individual who performed the survey; (7) Use radioactive gases only in areas of use and under conditions which have been evaluated and approved by the department for compliance with airborne release standards; and (8) Remove all radioactive material from the mobile vehicle and monitor the vehicle for contamination at the end of each day of use. [Eff 11/12/99] (Auth: HRS §§321-10, 321-11, 321-71) (Imp: HRS §§321-1, 321-11(21), 321-71)